A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Though small compared to each company’s total workforces, work stoppages have set uncomfortable precedents for management.
This month marks the end of what Goldman Sachs estimates will be a record year for stock buybacks, with a volume of roughly $930 billion.
In the first 11 months of the year, 1,991 CEOs have announced their departures, up 16% compared to the same timeframe last year.